Redox status is a key determinant in the fate of β-cell. These cells are not primarily detoxifying and thus do not possess extensive antioxidant defense machinery. However, they show a wide range of redox regulating proteins, such as peroxiredoxins, thioredoxins or thioredoxin reductases, etc., being functionally compartmentalized within the cells. They keep fragile redox homeostasis and serve as messengers and amplifiers of redox signaling. β-cells require proper redox signaling already in cell ontogenesis during the development of mature β-cells from their progenitors. We bring details about redox-regulated signaling pathways and transcription factors being essential for proper differentiation and maturation of functional β-cells and their proliferation and insulin expression/maturation. We briefly highlight the targets of redox signaling in the insulin secretory pathway and focus more on possible targets of extracellular redox signaling through secreted thioredoxin1 and thioredoxin reductase1. Tuned redox homeostasis can switch upon chronic pathological insults towards the dysfunction of β-cells and to glucose intolerance. These are characteristics of type 2 diabetes, which is often linked to chronic nutritional overload being nowadays a pandemic feature of lifestyle. Overcharged β-cell metabolism causes pressure on proteostasis in the endoplasmic reticulum, mainly due to increased demand on insulin synthesis, which establishes unfolded protein response and insulin misfolding along with excessive hydrogen peroxide production. This together with redox dysbalance in cytoplasm and mitochondria due to enhanced nutritional pressure impact β-cell redox homeostasis and establish prooxidative metabolism. This can further affect β-cell communication in pancreatic islets through gap junctions. In parallel, peripheral tissues losing insulin sensitivity and overall impairment of glucose tolerance and gut microbiota establish local proinflammatory signaling and later systemic metainflammation, i.e., low chronic inflammation prooxidative properties, which target β-cells leading to their dedifferentiation, dysfunction and eventually cell death.

1st Faculty of Medicine Charles University Katerinska 1660 32 121 08 Prague Czech Republic

Department of Mitochondrial Physiology Czech Academy of Sciences Videnska 1083 142 20 Prague 4 Czech Republic

Department of Mitochondrial Physiology Institute of Physiology Czech Academy of Sciences 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Leloup C., Tourrel-Cuzin C., Magnan C., Karaca M., Castel J., Carneiro L., Colombani A.L., Ktorza A., Casteilla L., Penicaud L. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes. 2009;58:673–681. doi: 10.2337/db07-1056. PubMed DOI PMC

Plecita-Hlavata L., Jaburek M., Holendova B., Tauber J., Pavluch V., Berkova Z., Cahova M., Schroeder K., Brandes R.P., Siemen D., et al. Glucose-Stimulated Insulin Secretion Fundamentally Requires H2O2 Signaling by NADPH Oxidase 4. Diabetes. 2020 doi: 10.2337/db19-1130. PubMed DOI

Wang J., Wang H. Oxidative Stress in Pancreatic Beta Cell Regeneration. Oxid. Med. Cell. Longev. 2017;2017:1930261. doi: 10.1155/2017/1930261. PubMed DOI PMC

Grankvist K., Marklund S.L., Taljedal I.B. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 1981;199:393–398. doi: 10.1042/bj1990393. PubMed DOI PMC

Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 1996;20:463–466. doi: 10.1016/0891-5849(96)02051-5. PubMed DOI

Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997;46:1733–1742. doi: 10.2337/diab.46.11.1733. PubMed DOI

Miki A., Ricordi C., Sakuma Y., Yamamoto T., Misawa R., Mita A., Molano R.D., Vaziri N.D., Pileggi A., Ichii H. Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation. PLoS ONE. 2018;13:e0196570. doi: 10.1371/journal.pone.0196570. PubMed DOI PMC

Kalinina E.V., Chernov N.N., Saprin A.N. Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes. Biochemistry. 2008;73:1493–1510. doi: 10.1134/S0006297908130099. PubMed DOI

Stancill J.S., Broniowska K.A., Oleson B.J., Naatz A., Corbett J.A. Pancreatic beta-cells detoxify H2O2 through the peroxiredoxin/thioredoxin antioxidant system. J. Biol. Chem. 2019;294:4843–4853. doi: 10.1074/jbc.RA118.006219. PubMed DOI PMC

Munro D., Treberg J.R. A radical shift in perspective: Mitochondria as regulators of reactive oxygen species. J. Exp. Biol. 2017;220:1170–1180. doi: 10.1242/jeb.132142. PubMed DOI

Roma L.P., Jonas J.C. Nutrient Metabolism, Subcellular Redox State, and Oxidative Stress in Pancreatic Islets and beta-Cells. J. Mol. Biol. 2019 doi: 10.1016/j.jmb.2019.10.012. PubMed DOI

Yoboue E.D., Sitia R., Simmen T. Redox crosstalk at endoplasmic reticulum (ER) membrane contact sites (MCS) uses toxic waste to deliver messages. Cell Death Dis. 2018;9:331. doi: 10.1038/s41419-017-0033-4. PubMed DOI PMC

Gurgul E., Lortz S., Tiedge M., Jorns A., Lenzen S. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes. 2004;53:2271–2280. doi: 10.2337/diabetes.53.9.2271. PubMed DOI

Plecita-Hlavata L., Engstova H., Jezek J., Holendova B., Tauber J., Petraskova L., Kren V., Jezek P. Potential of Mitochondria-Targeted Antioxidants to Prevent Oxidative Stress in Pancreatic beta-cells. Oxid. Med. Cell. Longev. 2019;2019:1826303. doi: 10.1155/2019/1826303. PubMed DOI PMC

Plecita-Hlavata L., Engstova H., Holendova B., Tauber J., Spacek T., Petraskova L., Kren V., Spackova J., Gotvaldova K., Jezek J., et al. Mitochondrial Superoxide Production Decreases on Glucose-Stimulated Insulin Secretion in Pancreatic beta Cells Due to Decreasing Mitochondrial Matrix NADH/NAD(+) Ratio. Antioxid. Redox Signal. 2020;33:789–815. doi: 10.1089/ars.2019.7800. PubMed DOI PMC

Jezek J., Dlaskova A., Zelenka J., Jaburek M., Jezek P. H(2)O(2)-Activated Mitochondrial Phospholipase iPLA(2)gamma Prevents Lipotoxic Oxidative Stress in Synergy with UCP2, Amplifies Signaling via G-Protein-Coupled Receptor GPR40, and Regulates Insulin Secretion in Pancreatic beta-Cells. Antioxid. Redox Signal. 2015;23:958–972. doi: 10.1089/ars.2014.6195. PubMed DOI PMC

Jezek P., Holendova B., Garlid K.D., Jaburek M. Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling. Antioxid. Redox Signal. 2018;29:667–714. doi: 10.1089/ars.2017.7225. PubMed DOI PMC

Appenzeller-Herzog C., Riemer J., Zito E., Chin K.T., Ron D., Spiess M., Ellgaard L. Disulphide production by Ero1alpha-PDI relay is rapid and effectively regulated. EMBO J. 2010;29:3318–3329. doi: 10.1038/emboj.2010.203. PubMed DOI PMC

Mehmeti I., Lortz S., Elsner M., Lenzen S. Peroxiredoxin 4 improves insulin biosynthesis and glucose-induced insulin secretion in insulin-secreting INS-1E cells. J. Biol. Chem. 2014;289:26904–26913. doi: 10.1074/jbc.M114.568329. PubMed DOI PMC

Lenzen S. Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic beta-cells. Biochim Biophys Acta Gen. Subj. 2017;1861:1929–1942. doi: 10.1016/j.bbagen.2017.05.013. PubMed DOI

Tavender T.J., Sheppard A.M., Bulleid N.J. Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem. J. 2008;411:191–199. doi: 10.1042/BJ20071428. PubMed DOI PMC

Nguyen V.D., Saaranen M.J., Karala A.R., Lappi A.K., Wang L., Raykhel I.B., Alanen H.I., Salo K.E., Wang C.C., Ruddock L.W. Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation. J. Mol. Biol. 2011;406:503–515. doi: 10.1016/j.jmb.2010.12.039. PubMed DOI

Hassler J.R., Scheuner D.L., Wang S., Han J., Kodali V.K., Li P., Nguyen J., George J.S., Davis C., Wu S.P., et al. The IRE1alpha/XBP1s Pathway Is Essential for the Glucose Response and Protection of beta Cells. PLoS Biol. 2015;13:e1002277. doi: 10.1371/journal.pbio.1002277. PubMed DOI PMC

Pearse B.R., Hebert D.N. Lectin chaperones help direct the maturation of glycoproteins in the endoplasmic reticulum. Biochim. Biophys. Acta. 2010;1803:684–693. doi: 10.1016/j.bbamcr.2009.10.008. PubMed DOI PMC

Plemper R.K., Bohmler S., Bordallo J., Sommer T., Wolf D.H. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature. 1997;388:891–895. doi: 10.1038/42276. PubMed DOI

Walter P., Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science. 2011;334:1081–1086. doi: 10.1126/science.1209038. PubMed DOI

Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2000;2:326–332. doi: 10.1038/35014014. PubMed DOI

Brozzi F., Eizirik D.L. ER stress and the decline and fall of pancreatic beta cells in type 1 diabetes. Ups J. Med. Sci. 2016;121:133–139. doi: 10.3109/03009734.2015.1135217. PubMed DOI PMC

Baboota R.K., Shinde A.B., Lemaire K., Fransen M., Vinckier S., Van Veldhoven P.P., Schuit F., Baes M. Functional peroxisomes are required for beta-cell integrity in mice. Mol. Metab. 2019;22:71–83. doi: 10.1016/j.molmet.2019.02.001. PubMed DOI PMC

Oliveira H.R., Verlengia R., Carvalho C.R., Britto L.R., Curi R., Carpinelli A.R. Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase. Diabetes. 2003;52:1457–1463. doi: 10.2337/diabetes.52.6.1457. PubMed DOI

Uchizono Y., Takeya R., Iwase M., Sasaki N., Oku M., Imoto H., Iida M., Sumimoto H. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 2006;80:133–139. doi: 10.1016/j.lfs.2006.08.031. PubMed DOI

Zhang Z., Li J., Yang L., Chen R., Yang R., Zhang H., Cai D., Chen H. The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells. J. Diabetes Res. 2014;2014:712781. doi: 10.1155/2014/712781. PubMed DOI PMC

Stancill J.S., Happ J.T., Broniowska K.A., Hogg N., Corbett J.A. Peroxiredoxin 1 plays a primary role in protecting pancreatic β-cells from hydrogen peroxide and peroxynitrite. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2020;318:R1004–R1013. doi: 10.1152/ajpregu.00011.2020. PubMed DOI PMC

Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999;274:21645–21650. doi: 10.1074/jbc.274.31.21645. PubMed DOI

Wondafrash D.Z., Nire’a A.T., Tafere G.G., Desta D.M., Berhe D.A., Zewdie K.A. Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications. Diabetes Metab. Syndr. Obes. 2020;13:43–51. doi: 10.2147/DMSO.S232221. PubMed DOI PMC

Yoshihara E., Masaki S., Matsuo Y., Chen Z., Tian H., Yodoi J. Thioredoxin/Txnip: Redoxisome, as a redox switch for the pathogenesis of diseases. Front. Immunol. 2014;4:514. doi: 10.3389/fimmu.2013.00514. PubMed DOI PMC

Nishinaka Y., Masutani H., Oka S., Matsuo Y., Yamaguchi Y., Nishio K., Ishii Y., Yodoi J. Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J. Biol. Chem. 2004;279:37559–37565. doi: 10.1074/jbc.M405473200. PubMed DOI

Xu G., Chen J., Jing G., Shalev A. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat. Med. 2013;19:1141–1146. doi: 10.1038/nm.3287. PubMed DOI PMC

Jing G., Westwell-Roper C., Chen J., Xu G., Verchere C.B., Shalev A. Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2. J. Biol. Chem. 2014;289:11807–11815. doi: 10.1074/jbc.M113.525022. PubMed DOI PMC

Pi J., Zhang Q., Fu J., Woods C.G., Hou Y., Corkey B.E., Collins S., Andersen M.E. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol. Appl. Pharm. 2010;244:77–83. doi: 10.1016/j.taap.2009.05.025. PubMed DOI PMC

Janjic D., Maechler P., Sekine N., Bartley C., Annen A.S., Wolheim C.B. Free radical modulation of insulin release in INS-1 cells exposed to alloxan. Biochem. Pharm. 1999;57:639–648. doi: 10.1016/S0006-2952(98)00346-3. PubMed DOI

Maechler P., Jornot L., Wollheim C.B. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J. Biol. Chem. 1999;274:27905–27913. doi: 10.1074/jbc.274.39.27905. PubMed DOI

Pi J., Bai Y., Zhang Q., Wong V., Floering L.M., Daniel K., Reece J.M., Deeney J.T., Andersen M.E., Corkey B.E., et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes. 2007;56:1783–1791. doi: 10.2337/db06-1601. PubMed DOI

Travasso R.D.M., Sampaio Dos Aidos F., Bayani A., Abranches P., Salvador A. Localized redox relays as a privileged mode of cytoplasmic hydrogen peroxide signaling. Redox Biol. 2017;12:233–245. doi: 10.1016/j.redox.2017.01.003. PubMed DOI PMC

Hanschmann E.M., Godoy J.R., Berndt C., Hudemann C., Lillig C.H. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: From cofactors to antioxidants to redox signaling. Antioxid. Redox Signal. 2013;19:1539–1605. doi: 10.1089/ars.2012.4599. PubMed DOI PMC

Kontou M., Will R.D., Adelfalk C., Wittig R., Poustka A., Hirsch-Kauffmann M., Schweiger M. Thioredoxin, a regulator of gene expression. Oncogene. 2004;23:2146–2152. doi: 10.1038/sj.onc.1207334. PubMed DOI

Bian M., Fan R., Zhao S., Liu W. Targeting the Thioredoxin System as a Strategy for Cancer Therapy. J. Med. Chem. 2019;62:7309–7321. doi: 10.1021/acs.jmedchem.8b01595. PubMed DOI

Jastrząb A., Skrzydlewska E. Thioredoxin-dependent system. Application of inhibitors. J. Enzym. Inhib. Med. Chem. 2021;36:362–371. doi: 10.1080/14756366.2020.1867121. PubMed DOI PMC

Muri J., Kopf M. Redox regulation of immunometabolism. Nat. Reviews. Immunol. 2020 doi: 10.1038/s41577-020-00478-8. PubMed DOI

Zhang J., Wang X., Vikash V., Ye Q., Wu D., Liu Y., Dong W. ROS and ROS-Mediated Cellular Signaling. Oxid. Med. Cell. Longev. 2016;2016:4350965. doi: 10.1155/2016/4350965. PubMed DOI PMC

Schultheis J., Beckmann D., Mulac D., Muller L., Esselen M., Dufer M. Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance. Oxid. Med. Cell. Longev. 2019;2019:7518510. doi: 10.1155/2019/7518510. PubMed DOI PMC

He J., Zhang X., Lian C., Wu J., Fang Y., Ye X. KEAP1/NRF2 axis regulates H2O2-induced apoptosis of pancreatic beta-cells. Gene. 2019;691:8–17. doi: 10.1016/j.gene.2018.11.100. PubMed DOI

Cardozo A.K., Heimberg H., Heremans Y., Leeman R., Kutlu B., Kruhoffer M., Orntoft T., Eizirik D.L. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 2001;276:48879–48886. doi: 10.1074/jbc.M108658200. PubMed DOI

Meyerovich K., Fukaya M., Terra L.F., Ortis F., Eizirik D.L., Cardozo A.K. The non-canonical NF-kappaB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro. Diabetologia. 2016;59:512–521. doi: 10.1007/s00125-015-3817-z. PubMed DOI

Meyerovich K., Ortis F., Cardozo A.K. The non-canonical NF-kappaB pathway and its contribution to beta-cell failure in diabetes. J. Mol. Endocrinol. 2018;61:F1–F6. doi: 10.1530/JME-16-0183. PubMed DOI

Lee K., Esselman W.J. Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways. Free Radic. Biol. Med. 2002;33:1121–1132. doi: 10.1016/S0891-5849(02)01000-6. PubMed DOI

Brigelius-Flohe R., Flohe L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 2011;15:2335–2381. doi: 10.1089/ars.2010.3534. PubMed DOI PMC

Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993;12:3095–3104. doi: 10.1002/j.1460-2075.1993.tb05978.x. PubMed DOI PMC

Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994;12:141–179. doi: 10.1146/annurev.iy.12.040194.001041. PubMed DOI

Cerf M.E. Transcription factors regulating beta-cell function. Eur. J. Endocrinol. 2006;155:671–679. doi: 10.1530/eje.1.02277. PubMed DOI

Jara M.A., Werneck-De-Castro J.P., Lubaczeuski C., Johnson J.D., Bernal-Mizrachi E. Pancreatic and duodenal homeobox-1 (PDX1) contributes to beta-cell mass expansion and proliferation induced by Akt/PKB pathway. Islets. 2020;12:32–40. doi: 10.1080/19382014.2020.1762471. PubMed DOI PMC

Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., Hanafusa T., Matsuzawa Y., Yamasaki Y., Hori M. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic beta-cells against glucose toxicity. Diabetes. 1999;48:2398–2406. doi: 10.2337/diabetes.48.12.2398. PubMed DOI

Tanaka Y., Gleason C.E., Tran P.O., Harmon J.S., Robertson R.P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. USA. 1999;96:10857–10862. doi: 10.1073/pnas.96.19.10857. PubMed DOI PMC

Matsuoka T.A., Kaneto H., Stein R., Miyatsuka T., Kawamori D., Henderson E., Kojima I., Matsuhisa M., Hori M., Yamasaki Y. MafA regulates expression of genes important to islet beta-cell function. Mol. Endocrinol. 2007;21:2764–2774. doi: 10.1210/me.2007-0028. PubMed DOI

Harmon J.S., Stein R., Robertson R.P. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J. Biol. Chem. 2005;280:11107–11113. doi: 10.1074/jbc.M410345200. PubMed DOI

Kondo T., El Khattabi I., Nishimura W., Laybutt D.R., Geraldes P., Shah S., King G., Bonner-Weir S., Weir G., Sharma A. p38 MAPK is a major regulator of MafA protein stability under oxidative stress. Mol. Endocrinol. 2009;23:1281–1290. doi: 10.1210/me.2008-0482. PubMed DOI PMC

El Khattabi I., Sharma A. Preventing p38 MAPK-mediated MafA degradation ameliorates beta-cell dysfunction under oxidative stress. Mol. Endocrinol. 2013;27:1078–1090. doi: 10.1210/me.2012-1346. PubMed DOI PMC

Harmon J.S., Bogdani M., Parazzoli S.D., Mak S.S., Oseid E.A., Berghmans M., Leboeuf R.C., Robertson R.P. beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology. 2009;150:4855–4862. doi: 10.1210/en.2009-0708. PubMed DOI PMC

Barthel A., Schmoll D., Unterman T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005;16:183–189. doi: 10.1016/j.tem.2005.03.010. PubMed DOI

Dansen T.B., Smits L.M., van Triest M.H., de Keizer P.L., van Leenen D., Koerkamp M.G., Szypowska A., Meppelink A., Brenkman A.B., Yodoi J., et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 2009;5:664–672. doi: 10.1038/nchembio.194. PubMed DOI

De Keizer P.L., Burgering B.M., Dansen T.B. Forkhead box o as a sensor, mediator, and regulator of redox signaling. Antioxid. Redox Signal. 2011;14:1093–1106. doi: 10.1089/ars.2010.3403. PubMed DOI

Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995;376:599–602. doi: 10.1038/376599a0. PubMed DOI

Huang X., Begley M., Morgenstern K.A., Gu Y., Rose P., Zhao H., Zhu X. Crystal structure of an inactive Akt2 kinase domain. Structure. 2003;11:21–30. doi: 10.1016/S0969-2126(02)00937-1. PubMed DOI

Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 2003;278:50226–50233. doi: 10.1074/jbc.M310171200. PubMed DOI

Kitamura T., Nakae J., Kitamura Y., Kido Y., Biggs W.H., 3rd, Wright C.V., White M.F., Arden K.C., Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Investig. 2002;110:1839–1847. doi: 10.1172/JCI200216857. PubMed DOI PMC

Kitamura Y.I., Kitamura T., Kruse J.P., Raum J.C., Stein R., Gu W., Accili D. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005;2:153–163. doi: 10.1016/j.cmet.2005.08.004. PubMed DOI

Nishimura W., Kondo T., Salameh T., El Khattabi I., Dodge R., Bonner-Weir S., Sharma A. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 2006;293:526–539. doi: 10.1016/j.ydbio.2006.02.028. PubMed DOI PMC

Cao X., Kambe F., Ohmori S., Seo H. Oxidoreductive modification of two cysteine residues in paired domain by Ref-1 regulates DNA-binding activity of Pax-8. Biochem. Biophys Res. Commun. 2002;297:288–293. doi: 10.1016/S0006-291X(02)02196-4. PubMed DOI

Walther C., Guenet J.L., Simon D., Deutsch U., Jostes B., Goulding M.D., Plachov D., Balling R., Gruss P. Pax: A murine multigene family of paired box-containing genes. Genomics. 1991;11:424–434. doi: 10.1016/0888-7543(91)90151-4. PubMed DOI

Swisa A., Avrahami D., Eden N., Zhang J., Feleke E., Dahan T., Cohen-Tayar Y., Stolovich-Rain M., Kaestner K.H., Glaser B., et al. PAX6 maintains beta cell identity by repressing genes of alternative islet cell types. J. Clin. Investig. 2017;127:230–243. doi: 10.1172/JCI88015. PubMed DOI PMC

Rieck S., Bankaitis E.D., Wright C.V. Seminars in Cell & Developmental Biology. Vol. 23. Academic Press; Cambridge, MA, USA: 2012. Lineage determinants in early endocrine development; pp. 673–684. PubMed DOI PMC

Bastidas-Ponce A., Roscioni S.S., Burtscher I., Bader E., Sterr M., Bakhti M., Lickert H. Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic beta-cells. Mol. Metab. 2017;6:524–534. doi: 10.1016/j.molmet.2017.03.007. PubMed DOI PMC

Bensellam M., Jonas J.C., Laybutt D.R. Mechanisms of beta-cell dedifferentiation in diabetes: Recent findings and future research directions. J. Endocrinol. 2018;236:R109–R143. doi: 10.1530/JOE-17-0516. PubMed DOI

Balakrishnan S., Dhavamani S., Prahalathan C. beta-Cell specific transcription factors in the context of diabetes mellitus and beta-cell regeneration. Mech. Dev. 2020;163:103634. doi: 10.1016/j.mod.2020.103634. PubMed DOI

Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455:627–632. doi: 10.1038/nature07314. PubMed DOI PMC

Chetboun M., Abitbol G., Rozenberg K., Rozenfeld H., Deutsch A., Sampson S.R., Rosenzweig T. Maintenance of redox state and pancreatic beta-cell function: Role of leptin and adiponectin. J. Cell. Biochem. 2012;113:1966–1976. doi: 10.1002/jcb.24065. PubMed DOI

Ahmed Alfar E., Kirova D., Konantz J., Birke S., Mansfeld J., Ninov N. Distinct Levels of Reactive Oxygen Species Coordinate Metabolic Activity with Beta-cell Mass Plasticity. Sci. Rep. 2017;7:3994. doi: 10.1038/s41598-017-03873-9. PubMed DOI PMC

Liang J., Wu S.Y., Zhang D., Wang L., Leung K.K., Leung P.S. NADPH Oxidase-Dependent Reactive Oxygen Species Stimulate beta-Cell Regeneration Through Differentiation of Endocrine Progenitors in Murine Pancreas. Antioxid. Redox Signal. 2016;24:419–433. doi: 10.1089/ars.2014.6135. PubMed DOI

Hoarau E., Chandra V., Rustin P., Scharfmann R., Duvillie B. Pro-oxidant/antioxidant balance controls pancreatic beta-cell differentiation through the ERK1/2 pathway. Cell Death Dis. 2014;5:e1487. doi: 10.1038/cddis.2014.441. PubMed DOI PMC

Costes S., Broca C., Bertrand G., Lajoix A.D., Bataille D., Bockaert J., Dalle S. ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: A key role in glucose-mediated pancreatic beta-cell survival. Diabetes. 2006;55:2220–2230. doi: 10.2337/db05-1618. PubMed DOI

Hussain M.A., Porras D.L., Rowe M.H., West J.R., Song W.J., Schreiber W.E., Wondisford F.E. Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation. Mol. Cell. Biol. 2006;26:7747–7759. doi: 10.1128/MCB.02353-05. PubMed DOI PMC

Piera-Velazquez S., Hawkins D.F., Whitecavage M.K., Colter D.C., Stokes D.G., Jimenez S.A. Regulation of the human SOX9 promoter by Sp1 and CREB. Exp. Cell Res. 2007;313:1069–1079. doi: 10.1016/j.yexcr.2007.01.001. PubMed DOI PMC

Le Belle J.E., Orozco N.M., Paucar A.A., Saxe J.P., Mottahedeh J., Pyle A.D., Wu H., Kornblum H.I. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell. 2011;8:59–71. doi: 10.1016/j.stem.2010.11.028. PubMed DOI PMC

Funato Y., Michiue T., Asashima M., Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 2006;8:501–508. doi: 10.1038/ncb1405. PubMed DOI

Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 2006;393:7–20. doi: 10.1042/BJ20051578. PubMed DOI PMC

Lee Y.H., Magkos F., Mantzoros C.S., Kang E.S. Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism. 2011;60:1664–1672. doi: 10.1016/j.metabol.2011.04.008. PubMed DOI

Kulkarni R.N., Wang Z.L., Wang R.M., Hurley J.D., Smith D.M., Ghatei M.A., Withers D.J., Gardiner J.V., Bailey C.J., Bloom S.R. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Investig. 1997;100:2729–2736. doi: 10.1172/JCI119818. PubMed DOI PMC

Kieffer T.J., Heller R.S., Leech C.A., Holz G.G., Habener J.F. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes. 1997;46:1087–1093. doi: 10.2337/diab.46.6.1087. PubMed DOI PMC

Kuehnen P., Laubner K., Raile K., Schofl C., Jakob F., Pilz I., Path G., Seufert J. Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic beta-cells and human pancreatic islets. Endocrinology. 2011;152:1800–1808. doi: 10.1210/en.2010-1094. PubMed DOI

Sim A.T., Baldwin M.L., Rostas J.A., Holst J., Ludowyke R.I. The role of serine/threonine protein phosphatases in exocytosis. Biochem. J. 2003;373:641–659. doi: 10.1042/bj20030484. PubMed DOI PMC

Staiger K., Stefan N., Staiger H., Brendel M.D., Brandhorst D., Bretzel R.G., Machicao F., Kellerer M., Stumvoll M., Fritsche A., et al. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J. Clin. Endocrinol. Metab. 2005;90:6707–6713. doi: 10.1210/jc.2005-0467. PubMed DOI

Llanos P., Contreras-Ferrat A., Barrientos G., Valencia M., Mears D., Hidalgo C. Glucose-Dependent Insulin Secretion in Pancreatic beta-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors. PLoS ONE. 2015;10:e0129238. doi: 10.1371/journal.pone.0129238. PubMed DOI PMC

Jansson D., Ng A.C., Fu A., Depatie C., Al Azzabi M., Screaton R.A. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc. Natl. Acad. Sci. USA. 2008;105:10161–10166. doi: 10.1073/pnas.0800796105. PubMed DOI PMC

Bernal-Mizrachi E., Kulkarni R.N., Scott D.K., Mauvais-Jarvis F., Stewart A.F., Garcia-Ocana A. Human beta-cell proliferation and intracellular signaling part 2: Still driving in the dark without a road map. Diabetes. 2014;63:819–831. doi: 10.2337/db13-1146. PubMed DOI PMC

Sato Y., Endo H., Okuyama H., Takeda T., Iwahashi H., Imagawa A., Yamagata K., Shimomura I., Inoue M. Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for insulin secretion in vitro. J. Biol. Chem. 2011;286:12524–12532. doi: 10.1074/jbc.M110.194738. PubMed DOI PMC

Zhdanov A.V., Ward M.W., Prehn J.H., Papkovsky D.B. Dynamics of intracellular oxygen in PC12 Cells upon stimulation of neurotransmission. J. Biol. Chem. 2008;283:5650–5661. doi: 10.1074/jbc.M706439200. PubMed DOI

O’Hagan K.A., Cocchiglia S., Zhdanov A.V., Tambuwala M.M., Cummins E.P., Monfared M., Agbor T.A., Garvey J.F., Papkovsky D.B., Taylor C.T., et al. PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc. Natl. Acad. Sci. USA. 2009;106:2188–2193. doi: 10.1073/pnas.0808801106. PubMed DOI PMC

Gerber P.A., Rutter G.A. The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid. Redox Signal. 2017;26:501–518. doi: 10.1089/ars.2016.6755. PubMed DOI PMC

Olsson R., Carlsson P.O. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes. 2011;60:2068–2075. doi: 10.2337/db09-0877. PubMed DOI PMC

Ashcroft F.M., Harrison D.E., Ashcroft S.J. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature. 1984;312:446–448. doi: 10.1038/312446a0. PubMed DOI

Yasui S., Mawatari K., Morizumi R., Furukawa H., Shimohata T., Harada N., Takahashi A., Nakaya Y. Hydrogen peroxide inhibits insulin-induced ATP-sensitive potassium channel activation independent of insulin signaling pathway in cultured vascular smooth muscle cells. J. Med. Investig. 2012;59:36–44. doi: 10.2152/jmi.59.36. PubMed DOI

Sakaguchi R., Mori Y. Transient receptor potential (TRP) channels: Biosensors for redox environmental stimuli and cellular status. Free Radic. Biol. Med. 2020;146:36–44. doi: 10.1016/j.freeradbiomed.2019.10.415. PubMed DOI

Finol-Urdaneta R.K., Remedi M.S., Raasch W., Becker S., Clark R.B., Struver N., Pavlov E., Nichols C.G., French R.J., Terlau H. Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion. EMBO Mol. Med. 2012;4:424–434. doi: 10.1002/emmm.201200218. PubMed DOI PMC

MacDonald P.E., Salapatek A.M., Wheeler M.B. Temperature and redox state dependence of native Kv2.1 currents in rat pancreatic beta-cells. J. Physiol. 2003;546:647–653. doi: 10.1113/jphysiol.2002.035709. PubMed DOI PMC

Mittal M., Gu X.Q., Pak O., Pamenter M.E., Haag D., Fuchs D.B., Schermuly R.T., Ghofrani H.A., Brandes R.P., Seeger W., et al. Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radic. Biol. Med. 2012;52:1033–1042. doi: 10.1016/j.freeradbiomed.2011.12.004. PubMed DOI

Gerst J.E. SNARE regulators: Matchmakers and matchbreakers. Biochim Biophys Acta. 2003;1641:99–110. doi: 10.1016/S0167-4889(03)00096-X. PubMed DOI

Ivarsson R., Quintens R., Dejonghe S., Tsukamoto K., Renstrom E., Schuit F.C. Redox control of exocytosis: Regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes. 2005;54:2132–2142. doi: 10.2337/diabetes.54.7.2132. PubMed DOI

Reinbothe T.M., Ivarsson R., Li D.Q., Niazi O., Jing X., Zhang E., Stenson L., Bryborn U., Renstrom E. Glutaredoxin-1 mediates NADPH-dependent stimulation of calcium-dependent insulin secretion. Mol. Endocrinol. 2009;23:893–900. doi: 10.1210/me.2008-0306. PubMed DOI PMC

Ferdaoussi M., Dai X., Jensen M.V., Wang R., Peterson B.S., Huang C., Ilkayeva O., Smith N., Miller N., Hajmrle C., et al. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional beta cells. J. Clin. Investig. 2015;125:3847–3860. doi: 10.1172/JCI82498. PubMed DOI PMC

Xu Z., Lam L.S., Lam L.H., Chau S.F., Ng T.B., Au S.W. Molecular basis of the redox regulation of SUMO proteases: A protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB J. 2008;22:127–137. doi: 10.1096/fj.06-7871com. PubMed DOI

Ferdaoussi M., MacDonald P.E. Toward Connecting Metabolism to the Exocytotic Site. Trends Cell Biol. 2017;27:163–171. doi: 10.1016/j.tcb.2016.10.003. PubMed DOI

Lorenzen I., Eble J.A., Hanschmann E.M. Thiol switches in membrane proteins - Extracellular redox regulation in cell biology. Biol. Chem. 2020 doi: 10.1515/hsz-2020-0266. PubMed DOI

Lundberg M., Fernandes A.P., Kumar S., Holmgren A. Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem. Biophys. Res. Commun. 2004;319:801–809. doi: 10.1016/j.bbrc.2004.04.199. PubMed DOI

Xiong B., Jha V., Min J.K., Cho J. Protein disulfide isomerase in cardiovascular disease. Exp. Mol. Med. 2020;52:390–399. doi: 10.1038/s12276-020-0401-5. PubMed DOI PMC

Mullen L., Hanschmann E.M., Lillig C.H., Herzenberg L.A., Ghezzi P. Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion. Mol. Med. 2015;21:98–108. doi: 10.2119/molmed.2015.00033. PubMed DOI PMC

Hanschmann E.M., Petry S.F., Eitner S., Maresch C.C., Lingwal N., Lillig C.H., Linn T. Paracrine regulation and improvement of β-cell function by thioredoxin. Redox Biol. 2020;34:101570. doi: 10.1016/j.redox.2020.101570. PubMed DOI PMC

Jikimoto T., Nishikubo Y., Koshiba M., Kanagawa S., Morinobu S., Morinobu A., Saura R., Mizuno K., Kondo S., Toyokuni S., et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol. Immunol. 2002;38:765–772. doi: 10.1016/S0161-5890(01)00113-4. PubMed DOI

Kakisaka Y., Nakashima T., Sumida Y., Yoh T., Nakamura H., Yodoi J., Senmaru H. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm. Metab. Res. 2002;34:160–164. doi: 10.1055/s-2002-23201. PubMed DOI

Asami K., Inagaki A., Imura T., Sekiguchi S., Fujimori K., Masutani H., Yodoi J., Satomi S., Ohuchi N., Goto M. Thioredoxin-1 attenuates early graft loss after intraportal islet transplantation in mice. PLoS ONE. 2013;8:e70259. doi: 10.1371/journal.pone.0070259. PubMed DOI PMC

Willems S.H., Tape C.J., Stanley P.L., Taylor N.A., Mills I.G., Neal D.E., McCafferty J., Murphy G. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 2010;428:439–450. doi: 10.1042/BJ20100179. PubMed DOI

Bass R., Edwards D.R. ADAMs and protein disulfide isomerase: The key to regulated cell-surface protein ectodomain shedding? Biochem. J. 2010;428:e3–e5. doi: 10.1042/BJ20100568. PubMed DOI

Düsterhöft S., Jung S., Hung C.W., Tholey A., Sönnichsen F.D., Grötzinger J., Lorenzen I. Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. J. Am. Chem. Soc. 2013;135:5776–5781. doi: 10.1021/ja400340u. PubMed DOI

Pedersen K.B., Chodavarapu H., Porretta C., Robinson L.K., Lazartigues E. Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice. Endocrinology. 2015;156:4411–4425. doi: 10.1210/en.2015-1556. PubMed DOI PMC

Chhabra K.H., Chodavarapu H., Lazartigues E. Angiotensin converting enzyme 2: A new important player in the regulation of glycemia. IUBMB Life. 2013;65:731–738. doi: 10.1002/iub.1190. PubMed DOI PMC

Bergerhausen L., Grosche J., Meißner J., Hecker C., Caliandro M.F., Westerhausen C., Kamenac A., Rezaei M., Mörgelin M., Poschmann G., et al. Extracellular Redox Regulation of α7β Integrin-Mediated Cell Migration Is Signaled via a Dominant Thiol-Switch. Antioxidants. 2020;9:227. doi: 10.3390/antiox9030227. PubMed DOI PMC

Passam F., Chiu J., Ju L., Pijning A., Jahan Z., Mor-Cohen R., Yeheskel A., Kolšek K., Thärichen L., Aponte-Santamaría C., et al. Mechano-redox control of integrin de-adhesion. eLife. 2018;7 doi: 10.7554/eLife.34843. PubMed DOI PMC

Townsend S.E., Gannon M. Extracellular Matrix-Associated Factors Play Critical Roles in Regulating Pancreatic β-Cell Proliferation and Survival. Endocrinology. 2019;160:1885–1894. doi: 10.1210/en.2019-00206. PubMed DOI PMC

Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell. 2002;110:673–687. doi: 10.1016/S0092-8674(02)00971-6. PubMed DOI

Alam N., Goel H.L., Zarif M.J., Butterfield J.E., Perkins H.M., Sansoucy B.G., Sawyer T.K., Languino L.R. The integrin-growth factor receptor duet. J. Cell. Physiol. 2007;213:649–653. doi: 10.1002/jcp.21278. PubMed DOI

Xu S.Z., Sukumar P., Zeng F., Li J., Jairaman A., English A., Naylor J., Ciurtin C., Majeed Y., Milligan C.J., et al. TRPC channel activation by extracellular thioredoxin. Nature. 2008;451:69–72. doi: 10.1038/nature06414. PubMed DOI PMC

Islam M.S. Molecular Regulations and Functions of the Transient Receptor Potential Channels of the Islets of Langerhans and Insulinoma Cells. Cells. 2020;9:685. doi: 10.3390/cells9030685. PubMed DOI PMC

Bensellam M., Van Lommel L., Overbergh L., Schuit F.C., Jonas J.C. Cluster analysis of rat pancreatic islet gene mRNA levels after culture in low-, intermediate- and high-glucose concentrations. Diabetologia. 2009;52:463–476. doi: 10.1007/s00125-008-1245-z. PubMed DOI

Corkey B.E., Deeney J.T. The Redox Communication Network as a Regulator of Metabolism. Front. Physiol. 2020;11:567796. doi: 10.3389/fphys.2020.567796. PubMed DOI PMC

Corkey B.E., Shirihai O. Metabolic master regulators: Sharing information among multiple systems. Trends Endocrinol. Metab. 2012;23:594–601. doi: 10.1016/j.tem.2012.07.006. PubMed DOI PMC

Scheuner D., Kaufman R.J. The unfolded protein response: A pathway that links insulin demand with beta-cell failure and diabetes. Endocr. Rev. 2008;29:317–333. doi: 10.1210/er.2007-0039. PubMed DOI PMC

Ghosh R., Colon-Negron K., Papa F.R. Endoplasmic reticulum stress, degeneration of pancreatic islet beta-cells, and therapeutic modulation of the unfolded protein response in diabetes. Mol. Metab. 2019;27S:S60–S68. doi: 10.1016/j.molmet.2019.06.012. PubMed DOI PMC

Herbert T.P., Laybutt D.R. A Reevaluation of the Role of the Unfolded Protein Response in Islet Dysfunction: Maladaptation or a Failure to Adapt? Diabetes. 2016;65:1472–1480. doi: 10.2337/db15-1633. PubMed DOI

Escribano-Lopez I., Banuls C., Diaz-Morales N., Iannantuoni F., Rovira-Llopis S., Gomis R., Rocha M., Hernandez-Mijares A., Murphy M.P., Victor V.M. The Mitochondria-Targeted Antioxidant MitoQ Modulates Mitochondrial Function and Endoplasmic Reticulum Stress in Pancreatic beta Cells Exposed to Hyperglycaemia. Cell Physiol. Biochem. 2019;52:186–197. doi: 10.33594/000000013. PubMed DOI

Zeeshan H.M., Lee G.H., Kim H.R., Chae H.J. Endoplasmic Reticulum Stress and Associated ROS. Int. J. Mol. Sci. 2016;17:327. doi: 10.3390/ijms17030327. PubMed DOI PMC

Yuan Q., Tang W., Zhang X., Hinson J.A., Liu C., Osei K., Wang J. Proinsulin atypical maturation and disposal induces extensive defects in mouse Ins2+/Akita beta-cells. PLoS ONE. 2012;7:e35098. doi: 10.1371/journal.pone.0035098. PubMed DOI PMC

Oslowski C.M., Hara T., O’Sullivan-Murphy B., Kanekura K., Lu S., Hara M., Ishigaki S., Zhu L.J., Hayashi E., Hui S.T., et al. Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab. 2012;16:265–273. doi: 10.1016/j.cmet.2012.07.005. PubMed DOI PMC

Vasiljevic J., Torkko J.M., Knoch K.P., Solimena M. The making of insulin in health and disease. Diabetologia. 2020;63:1981–1989. doi: 10.1007/s00125-020-05192-7. PubMed DOI PMC

Plaisance V., Brajkovic S., Tenenbaum M., Favre D., Ezanno H., Bonnefond A., Bonner C., Gmyr V., Kerr-Conte J., Gauthier B.R., et al. Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL. PLoS ONE. 2016;11:e0163046. doi: 10.1371/journal.pone.0163046. PubMed DOI PMC

Bravo R., Gutierrez T., Paredes F., Gatica D., Rodriguez A.E., Pedrozo Z., Chiong M., Parra V., Quest A.F., Rothermel B.A., et al. Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics. Int. J. Biochem. Cell Biol. 2012;44:16–20. doi: 10.1016/j.biocel.2011.10.012. PubMed DOI PMC

Imai Y., Dobrian A.D., Morris M.A., Nadler J.L. Islet inflammation: A unifying target for diabetes treatment? Trends Endocrinol. Metab. 2013;24:351–360. doi: 10.1016/j.tem.2013.01.007. PubMed DOI PMC

Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., Yagi N., Ohto U., Kimoto M., Miyake K., et al. Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab. 2012;15:518–533. doi: 10.1016/j.cmet.2012.01.023. PubMed DOI

Kim J.J., Sears D.D. TLR4 and Insulin Resistance. Gastroenterol. Res. Pract. 2010;2010 doi: 10.1155/2010/212563. PubMed DOI PMC

Singh A., Singh V., Tiwari R.L., Chandra T., Kumar A., Dikshit M., Barthwal M.K. The IRAK-ERK-p67phox-Nox-2 axis mediates TLR4, 2-induced ROS production for IL-1beta transcription and processing in monocytes. Cell. Mol. Immunol. 2016;13:745–763. doi: 10.1038/cmi.2015.62. PubMed DOI PMC

Park H.S., Jung H.Y., Park E.Y., Kim J., Lee W.J., Bae Y.S. Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 2004;173:3589–3593. doi: 10.4049/jimmunol.173.6.3589. PubMed DOI

Marseglia L., Manti S., D’Angelo G., Nicotera A., Parisi E., Di Rosa G., Gitto E., Arrigo T. Oxidative stress in obesity: A critical component in human diseases. Int. J. Mol. Sci. 2014;16:378–400. doi: 10.3390/ijms16010378. PubMed DOI PMC

Han C.Y. Roles of Reactive Oxygen Species on Insulin Resistance in Adipose Tissue. Diabetes Metab. J. 2016;40:272–279. doi: 10.4093/dmj.2016.40.4.272. PubMed DOI PMC

David J.A., Rifkin W.J., Rabbani P.S., Ceradini D.J. The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus. J. Diabetes Res. 2017;2017:4826724. doi: 10.1155/2017/4826724. PubMed DOI PMC

Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 2003;112:1796–1808. doi: 10.1172/JCI200319246. PubMed DOI PMC

Lieb D.C., Brotman J.J., Hatcher M.A., Aye M.S., Cole B.K., Haynes B.A., Wohlgemuth S.D., Fontana M.A., Beydoun H., Nadler J.L., et al. Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes. J. Clin. Endocrinol. Metab. 2014;99:E1713–E1720. doi: 10.1210/jc.2013-4461. PubMed DOI PMC

Dunmore S.J., Brown J.E. The role of adipokines in beta-cell failure of type 2 diabetes. J. Endocrinol. 2013;216:T37–T45. doi: 10.1530/JOE-12-0278. PubMed DOI

Tushuizen M.E., Bunck M.C., Pouwels P.J., Bontemps S., van Waesberghe J.H., Schindhelm R.K., Mari A., Heine R.J., Diamant M. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30:2916–2921. doi: 10.2337/dc07-0326. PubMed DOI

Ying W., Lee Y.S., Dong Y., Seidman J.S., Yang M., Isaac R., Seo J.B., Yang B.H., Wollam J., Riopel M., et al. Expansion of Islet-Resident Macrophages Leads to Inflammation Affecting beta Cell Proliferation and Function in Obesity. Cell Metab. 2019;29:457–474.e455. doi: 10.1016/j.cmet.2018.12.003. PubMed DOI PMC

Weitz J.R., Makhmutova M., Almaca J., Stertmann J., Aamodt K., Brissova M., Speier S., Rodriguez-Diaz R., Caicedo A. Mouse pancreatic islet macrophages use locally released ATP to monitor beta cell activity. Diabetologia. 2018;61:182–192. doi: 10.1007/s00125-017-4416-y. PubMed DOI PMC

Jacques-Silva M.C., Correa-Medina M., Cabrera O., Rodriguez-Diaz R., Makeeva N., Fachado A., Diez J., Berman D.M., Kenyon N.S., Ricordi C., et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc. Natl. Acad. Sci. USA. 2010;107:6465–6470. doi: 10.1073/pnas.0908935107. PubMed DOI PMC

Almaca J., Molina J., Menegaz D., Pronin A.N., Tamayo A., Slepak V., Berggren P.O., Caicedo A. Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells. Cell Rep. 2016;17:3281–3291. doi: 10.1016/j.celrep.2016.11.072. PubMed DOI PMC

Riley K.G., Pasek R.C., Maulis M.F., Dunn J.C., Bolus W.R., Kendall P.L., Hasty A.H., Gannon M. Macrophages are essential for CTGF-mediated adult beta-cell proliferation after injury. Mol. Metab. 2015;4:584–591. doi: 10.1016/j.molmet.2015.05.002. PubMed DOI PMC

Boni-Schnetzler M., Meier D.T. Islet inflammation in type 2 diabetes. Semin Immunopathol. 2019;41:501–513. doi: 10.1007/s00281-019-00745-4. PubMed DOI PMC

Ying W., Fu W., Lee Y.S., Olefsky J.M. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat. Rev. Endocrinol. 2020;16:81–90. doi: 10.1038/s41574-019-0286-3. PubMed DOI PMC

Ehses J.A., Perren A., Eppler E., Ribaux P., Pospisilik J.A., Maor-Cahn R., Gueripel X., Ellingsgaard H., Schneider M.K., Biollaz G., et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56:2356–2370. doi: 10.2337/db06-1650. PubMed DOI

Shin K.C., Hwang I., Choe S.S., Park J., Ji Y., Kim J.I., Lee G.Y., Choi S.H., Ching J., Kovalik J.P., et al. Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation. Nat. Commun. 2017;8:1087. doi: 10.1038/s41467-017-01232-w. PubMed DOI PMC

Boni-Schnetzler M., Thorne J., Parnaud G., Marselli L., Ehses J.A., Kerr-Conte J., Pattou F., Halban P.A., Weir G.C., Donath M.Y. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J. Clin. Endocrinol. Metab. 2008;93:4065–4074. doi: 10.1210/jc.2008-0396. PubMed DOI PMC

Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011;12:408–415. doi: 10.1038/ni.2022. PubMed DOI PMC

Westwell-Roper C., Denroche H.C., Ehses J.A., Verchere C.B. Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates. J. Biol. Chem. 2016;291:8908–8917. doi: 10.1074/jbc.M115.712455. PubMed DOI PMC

Cardozo A.K., Ortis F., Storling J., Feng Y.M., Rasschaert J., Tonnesen M., Van Eylen F., Mandrup-Poulsen T., Herchuelz A., Eizirik D.L. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes. 2005;54:452–461. doi: 10.2337/diabetes.54.2.452. PubMed DOI

Kawamori D., Kaneto H., Nakatani Y., Matsuoka T.A., Matsuhisa M., Hori M., Yamasaki Y. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J. Biol. Chem. 2006;281:1091–1098. doi: 10.1074/jbc.M508510200. PubMed DOI

Kaneto H., Xu G., Fujii N., Kim S., Bonner-Weir S., Weir G.C. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 2002;277:30010–30018. doi: 10.1074/jbc.M202066200. PubMed DOI

Burke S.J., Batdorf H.M., Burk D.H., Martin T.M., Mendoza T., Stadler K., Alami W., Karlstad M.D., Robson M.J., Blakely R.D., et al. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet beta-cell de-differentiation. Mol. Metab. 2018;14:95–107. doi: 10.1016/j.molmet.2018.06.003. PubMed DOI PMC

Nordmann T.M., Dror E., Schulze F., Traub S., Berishvili E., Barbieux C., Boni-Schnetzler M., Donath M.Y. The Role of Inflammation in beta-cell Dedifferentiation. Sci. Rep. 2017;7:6285. doi: 10.1038/s41598-017-06731-w. PubMed DOI PMC

Wang Q., Zhang H., Zhao B., Fei H. IL-1beta caused pancreatic beta-cells apoptosis is mediated in part by endoplasmic reticulum stress via the induction of endoplasmic reticulum Ca2+ release through the c-Jun N-terminal kinase pathway. Mol. Cell. Biochem. 2009;324:183–190. doi: 10.1007/s11010-008-9997-9. PubMed DOI

Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., Ojcius D.M. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 2007;282:2871–2879. doi: 10.1074/jbc.M608083200. PubMed DOI PMC

Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010;11:136–140. doi: 10.1038/ni.1831. PubMed DOI

Dror E., Dalmas E., Meier D.T., Wueest S., Thevenet J., Thienel C., Timper K., Nordmann T.M., Traub S., Schulze F., et al. Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 2017;18:283–292. doi: 10.1038/ni.3659. PubMed DOI

Herder C., Dalmas E., Boni-Schnetzler M., Donath M.Y. The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications. Trends Endocrinol. Metab. 2015;26:551–563. doi: 10.1016/j.tem.2015.08.001. PubMed DOI

Sokolova M., Sahraoui A., Hoyem M., Ogaard J., Lien E., Aukrust P., Yndestad A., Ranheim T., Scholz H. NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction. Am. J. Physiol. Endocrinol. Metab. 2018;315:E912–E923. doi: 10.1152/ajpendo.00461.2017. PubMed DOI

Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60. doi: 10.1038/nature11450. PubMed DOI

Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541–546. doi: 10.1038/nature12506. PubMed DOI

Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013;7:880–884. doi: 10.1038/ismej.2012.153. PubMed DOI PMC

Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414. PubMed DOI

Mollica M.P., Mattace Raso G., Cavaliere G., Trinchese G., De Filippo C., Aceto S., Prisco M., Pirozzi C., Di Guida F., Lama A., et al. Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice. Diabetes. 2017;66:1405–1418. doi: 10.2337/db16-0924. PubMed DOI

Vezza T., Abad-Jimenez Z., Marti-Cabrera M., Rocha M., Victor V.M. Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes. Antioxidants. 2020;9:848. doi: 10.3390/antiox9090848. PubMed DOI PMC

Liu J.L., Segovia I., Yuan X.L., Gao Z.H. Controversial Roles of Gut Microbiota-Derived Short-Chain Fatty Acids (SCFAs) on Pancreatic beta-Cell Growth and Insulin Secretion. Int. J. Mol. Sci. 2020;21:910. doi: 10.3390/ijms21030910. PubMed DOI PMC

Christensen D.P., Dahllof M., Lundh M., Rasmussen D.N., Nielsen M.D., Billestrup N., Grunnet L.G., Mandrup-Poulsen T. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol. Med. 2011;17:378–390. doi: 10.2119/molmed.2011.00021. PubMed DOI PMC

Rohr M.W., Narasimhulu C.A., Rudeski-Rohr T.A., Parthasarathy S. Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv. Nutr. 2020;11:77–91. doi: 10.1093/advances/nmz061. PubMed DOI PMC

Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., Smirnova N., Berge M., Sulpice T., Lahtinen S., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: Molecular mechanisms and probiotic treatment. EMBO Mol. Med. 2011;3:559–572. doi: 10.1002/emmm.201100159. PubMed DOI PMC

Cohrs C.M., Panzer J.K., Drotar D.M., Enos S.J., Kipke N., Chen C., Bozsak R., Schoniger E., Ehehalt F., Distler M., et al. Dysfunction of Persisting beta Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis. Cell Rep. 2020;31:107469. doi: 10.1016/j.celrep.2020.03.033. PubMed DOI

Da Silva Xavier G., Rutter G.A. Metabolic and Functional Heterogeneity in Pancreatic beta Cells. J. Mol. Biol. 2020;432:1395–1406. doi: 10.1016/j.jmb.2019.08.005. PubMed DOI

Robertson R.P., Harmon J.S. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. Free Radic. Biol. Med. 2006;41:177–184. doi: 10.1016/j.freeradbiomed.2005.04.030. PubMed DOI

Guo S., Dai C., Guo M., Taylor B., Harmon J.S., Sander M., Robertson R.P., Powers A.C., Stein R. Inactivation of specific beta cell transcription factors in type 2 diabetes. J. Clin. Investig. 2013;123:3305–3316. doi: 10.1172/JCI65390. PubMed DOI PMC

Mahadevan J., Parazzoli S., Oseid E., Hertzel A.V., Bernlohr D.A., Vallerie S.N., Liu C.Q., Lopez M., Harmon J.S., Robertson R.P. Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves beta-cell mass and function in ZDF rats. Diabetes. 2013;62:3582–3588. doi: 10.2337/db13-0357. PubMed DOI PMC

Kawamori D., Kajimoto Y., Kaneto H., Umayahara Y., Fujitani Y., Miyatsuka T., Watada H., Leibiger I.B., Yamasaki Y., Hori M. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. Diabetes. 2003;52:2896–2904. doi: 10.2337/diabetes.52.12.2896. PubMed DOI

Talchai C., Xuan S., Lin H.V., Sussel L., Accili D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell. 2012;150:1223–1234. doi: 10.1016/j.cell.2012.07.029. PubMed DOI PMC

Kim-Muller J.Y., Zhao S., Srivastava S., Mugabo Y., Noh H.L., Kim Y.R., Madiraju S.R., Ferrante A.W., Skolnik E.Y., Prentki M., et al. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab. 2014;20:593–602. doi: 10.1016/j.cmet.2014.08.012. PubMed DOI PMC

Cinti F., Bouchi R., Kim-Muller J.Y., Ohmura Y., Sandoval P.R., Masini M., Marselli L., Suleiman M., Ratner L.E., Marchetti P., et al. Evidence of beta-Cell Dedifferentiation in Human Type 2 Diabetes. J. Clin. Endocrinol. Metab. 2016;101:1044–1054. doi: 10.1210/jc.2015-2860. PubMed DOI PMC

Klotz L.O., Sanchez-Ramos C., Prieto-Arroyo I., Urbanek P., Steinbrenner H., Monsalve M. Redox regulation of FoxO transcription factors. Redox Biol. 2015;6:51–72. doi: 10.1016/j.redox.2015.06.019. PubMed DOI PMC

Dorrell C., Schug J., Canaday P.S., Russ H.A., Tarlow B.D., Grompe M.T., Horton T., Hebrok M., Streeter P.R., Kaestner K.H., et al. Human islets contain four distinct subtypes of beta cells. Nat. Commun. 2016;7:11756. doi: 10.1038/ncomms11756. PubMed DOI PMC

Rutter G.A., Georgiadou E., Martinez-Sanchez A., Pullen T.J. Metabolic and functional specialisations of the pancreatic beta cell: Gene disallowance, mitochondrial metabolism and intercellular connectivity. Diabetologia. 2020;63:1990–1998. doi: 10.1007/s00125-020-05205-5. PubMed DOI PMC

Sasaki M., Fujimoto S., Sato Y., Nishi Y., Mukai E., Yamano G., Sato H., Tahara Y., Ogura K., Nagashima K., et al. Reduction of reactive oxygen species ameliorates metabolism-secretion coupling in islets of diabetic GK rats by suppressing lactate overproduction. Diabetes. 2013;62:1996–2003. doi: 10.2337/db12-0903. PubMed DOI PMC

Bensellam M., Duvillie B., Rybachuk G., Laybutt D.R., Magnan C., Guiot Y., Pouyssegur J., Jonas J.C. Glucose-induced O(2) consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS ONE. 2012;7:e29807. doi: 10.1371/journal.pone.0029807. PubMed DOI PMC

Sato Y., Inoue M., Yoshizawa T., Yamagata K. Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes. PLoS ONE. 2014;9:e114868. doi: 10.1371/journal.pone.0114868. PubMed DOI PMC

Li X., Zhang L., Meshinchi S., Dias-Leme C., Raffin D., Johnson J.D., Treutelaar M.K., Burant C.F. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes. 2006;55:2965–2973. doi: 10.2337/db06-0733. PubMed DOI

Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Science’s STKE: Signal transduction knowledge environment. Sci. Stke. 2007;2007:cm8. doi: 10.1126/stke.4072007cm8. PubMed DOI

Jiang B.H., Rue E., Wang G.L., Roe R., Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 1996;271:17771–17778. doi: 10.1074/jbc.271.30.17771. PubMed DOI

Lee J.W., Bae S.H., Jeong J.W., Kim S.H., Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp. Mol. Med. 2004;36:1–12. doi: 10.1038/emm.2004.1. PubMed DOI

Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3:187–197. doi: 10.1016/j.cmet.2006.01.012. PubMed DOI

Liu N., Cai X., Liu T., Zou J., Wang L., Wang G., Liu Y., Ding X., Zhang B., Sun P., et al. Hypoxia-inducible factor-1α mediates the expression of mature β cell-disallowed genes in hypoxia-induced β cell dedifferentiation. Biochem. Biophys. Res. Commun. 2020;523:382–388. doi: 10.1016/j.bbrc.2019.12.063. PubMed DOI

Giuliani M., Moritz W., Bodmer E., Dindo D., Kugelmeier P., Lehmann R., Gassmann M., Groscurth P., Weber M. Central necrosis in isolated hypoxic human pancreatic islets: Evidence for postisolation ischemia. Cell Transplant. 2005;14:67–76. doi: 10.3727/000000005783983287. PubMed DOI

Fang Y., Zhang Q., Tan J., Li L., An X., Lei P. Intermittent hypoxia-induced rat pancreatic β-cell apoptosis and protective effects of antioxidant intervention. Nutr. Diabetes. 2014;4:e131. doi: 10.1038/nutd.2014.28. PubMed DOI PMC

Zheng X., Zheng X., Wang X., Ma Z., Gupta Sunkari V., Botusan I., Takeda T., Björklund A., Inoue M., Catrina S.B., et al. Acute hypoxia induces apoptosis of pancreatic β-cell by activation of the unfolded protein response and upregulation of CHOP. Cell Death Dis. 2012;3:e322. doi: 10.1038/cddis.2012.66. PubMed DOI PMC

Bensellam M., Montgomery M.K., Luzuriaga J., Chan J.Y., Laybutt D.R. Inhibitor of differentiation proteins protect against oxidative stress by regulating the antioxidant-mitochondrial response in mouse beta cells. Diabetologia. 2015;58:758–770. doi: 10.1007/s00125-015-3503-1. PubMed DOI

Wang Y.J., Schug J., Won K.J., Liu C., Naji A., Avrahami D., Golson M.L., Kaestner K.H. Single-Cell Transcriptomics of the Human Endocrine Pancreas. Diabetes. 2016;65:3028–3038. doi: 10.2337/db16-0405. PubMed DOI PMC

Zhang T., Kim D.H., Xiao X., Lee S., Gong Z., Muzumdar R., Calabuig-Navarro V., Yamauchi J., Harashima H., Wang R., et al. FoxO1 Plays an Important Role in Regulating beta-Cell Compensation for Insulin Resistance in Male Mice. Endocrinology. 2016;157:1055–1070. doi: 10.1210/en.2015-1852. PubMed DOI PMC

Cabrera O., Berman D.M., Kenyon N.S., Ricordi C., Berggren P.O., Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA. 2006;103:2334–2339. doi: 10.1073/pnas.0510790103. PubMed DOI PMC

Gilon P., Shepherd R.M., Henquin J.C. Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J. Biol. Chem. 1993;268:22265–22268. doi: 10.1016/S0021-9258(18)41522-0. PubMed DOI

Jacob S., Kohler M., Troster P., Visa M., Garcia-Prieto C.F., Alanentalo T., Moede T., Leibiger B., Leibiger I.B., Berggren P.O. In vivo Ca(2+) dynamics in single pancreatic beta cells. FASEB J. 2020;34:945–959. doi: 10.1096/fj.201901302RR. PubMed DOI

Frank J.A., Broichhagen J., Yushchenko D.A., Trauner D., Schultz C., Hodson D.J. Optical tools for understanding the complexity of beta-cell signalling and insulin release. Nat. Rev. Endocrinol. 2018;14:721–737. doi: 10.1038/s41574-018-0105-2. PubMed DOI

Johnston N.R., Mitchell R.K., Haythorne E., Pessoa M.P., Semplici F., Ferrer J., Piemonti L., Marchetti P., Bugliani M., Bosco D., et al. Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose. Cell Metab. 2016;24:389–401. doi: 10.1016/j.cmet.2016.06.020. PubMed DOI PMC

Salem V., Silva L.D., Suba K., Georgiadou E., Neda Mousavy Gharavy S., Akhtar N., Martin-Alonso A., Gaboriau D.C.A., Rothery S.M., Stylianides T., et al. Leader beta-cells coordinate Ca(2+) dynamics across pancreatic islets in vivo. Nat. Metab. 2019;1:615–629. doi: 10.1038/s42255-019-0075-2. PubMed DOI

Benninger R.K., Zhang M., Head W.S., Satin L.S., Piston D.W. Gap junction coupling and calcium waves in the pancreatic islet. Biophys. J. 2008;95:5048–5061. doi: 10.1529/biophysj.108.140863. PubMed DOI PMC

Head W.S., Orseth M.L., Nunemaker C.S., Satin L.S., Piston D.W., Benninger R.K. Connexin-36 gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes. 2012;61:1700–1707. doi: 10.2337/db11-1312. PubMed DOI PMC

Corezola do Amaral M.E., Kravets V., Dwulet J.M., Farnsworth N.L., Piscopio R., Schleicher W.E., Miranda J.G., Benninger R.K.P. Caloric restriction recovers impaired beta-cell-beta-cell gap junction coupling, calcium oscillation coordination, and insulin secretion in prediabetic mice. Am. J. Physiol. Endocrinol. Metab. 2020;319:E709–E720. doi: 10.1152/ajpendo.00132.2020. PubMed DOI PMC

Retamal M.A., Garcia I.E., Pinto B.I., Pupo A., Baez D., Stehberg J., Del Rio R., Gonzalez C. Extracellular Cysteine in Connexins: Role as Redox Sensors. Front. Physiol. 2016;7:1. doi: 10.3389/fphys.2016.00001. PubMed DOI PMC

Taneera J., Lang S., Sharma A., Fadista J., Zhou Y., Ahlqvist E., Jonsson A., Lyssenko V., Vikman P., Hansson O., et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012;16:122–134. doi: 10.1016/j.cmet.2012.06.006. PubMed DOI

Taneera J., Fadista J., Ahlqvist E., Zhang M., Wierup N., Renström E., Groop L. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes. Mol. Cell. Endocrinol. 2013;375:35–42. doi: 10.1016/j.mce.2013.05.003. PubMed DOI

Kanatsuna N., Taneera J., Vaziri-Sani F., Wierup N., Larsson H.E., Delli A., Skärstrand H., Balhuizen A., Bennet H., Steiner D.F., et al. Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets. J. Biol. Chem. 2013;288:29013–29023. doi: 10.1074/jbc.M113.478222. PubMed DOI PMC

Hänzelmann S., Wang J., Güney E., Tang Y., Zhang E., Axelsson A.S., Nenonen H., Salehi A.S., Wollheim C.B., Zetterberg E., et al. Thrombin stimulates insulin secretion via protease-activated receptor-3. Islets. 2015;7:e1118195. doi: 10.1080/19382014.2015.1118195. PubMed DOI PMC

Karolina D.S., Armugam A., Tavintharan S., Wong M.T., Lim S.C., Sum C.F., Jeyaseelan K. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS ONE. 2011;6:e22839. doi: 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622. PubMed DOI PMC

Dominguez V., Raimondi C., Somanath S., Bugliani M., Loder M.K., Edling C.E., Divecha N., da Silva-Xavier G., Marselli L., Persaud S.J., et al. Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells. J. Biol. Chem. 2011;286:4216–4225. doi: 10.1074/jbc.M110.200295. PubMed DOI PMC

Redox Status as a Key Driver of Healthy Pancreatic Beta-Cells

Cysteine residues in signal transduction and its relevance in pancreatic beta cells

Contribution of Mitochondria to Insulin Secretion by Various Secretagogues

Mitochondrial Redox Regulations and Redox Biology of Mitochondria